Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 161

Results For "ENT"

10647 News Found

Quantumzyme receives patent for development of green catalyst in India
News | March 25, 2023

Quantumzyme receives patent for development of green catalyst in India

The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions


Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData
News | March 25, 2023

Pfizer acquisition of ADC trailblazer Seagen a worthy investment: GlobalData

Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.


Lupin receives tentative approval from USFDA for Obeticholic Acid Tablets
Drug Approval | March 24, 2023

Lupin receives tentative approval from USFDA for Obeticholic Acid Tablets

Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).


Emmes acquires Essex Management
News | March 23, 2023

Emmes acquires Essex Management

Essex enriches and complements Emmes’ services


OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes
Healthcare | March 23, 2023

OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes

This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India


Investment in healthcare workforce key to accelerating India’s economic growth: Experts
Healthcare | March 23, 2023

Investment in healthcare workforce key to accelerating India’s economic growth: Experts

Integration of modern and traditional medicine to facilitate the illness to wellness journey


Zydus receives final and tentative approval from USFDA for Tofacitinib Tablets
Drug Approval | March 22, 2023

Zydus receives final and tentative approval from USFDA for Tofacitinib Tablets

Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)


Patritumab Deruxtecan shows better clinical activity in patient with lung and breast cancer
Clinical Trials | March 20, 2023

Patritumab Deruxtecan shows better clinical activity in patient with lung and breast cancer

Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session


Drug coated balloons is an alternative to stents in younger patients: Experts
News | March 18, 2023

Drug coated balloons is an alternative to stents in younger patients: Experts

This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective


Lupin Digital Health reveals results of digital therapeutics study with ACS patients
Digitisation | March 18, 2023

Lupin Digital Health reveals results of digital therapeutics study with ACS patients

The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform